Keeping Wound Care Patients out of the ER: EO2 Announces Next Generation Oxygen Delivery System for Full Wound Closure At-Home

SAN ANTONIO, July 2020 – EO2 Concepts® announced today the release of an

enhanced version of their full wound closure, at-home therapy system. The upgrade of the system consists of new and improved features for both the medical device, called the OxyGeni® and the OxySpur® wound dressings.

The OxyGeni and the OxySpur Oxygen Diffusion Dressings combine to provide a standalone,

full wound closure system that provides Continuous Diffusion of Oxygen (CDO) Therapy. The system provides advanced wound care therapy a continuous (24/7) flow of pure humidified oxygen, that is silent and discreetly and worn by the patient. CDO Therapy and the simplicity of

the system offer full closure and pain relief to patients

suffering with chronic wounds, including diabetic and other healing-compromised patients. The upgrades to the system will allow many patients at high risk for COVID-19 to stay safe at home, while still receiving an advanced oxygen treatment prescribed by physicians using new telehelath programs.

The OxyGeni now replaces the TransCu O2 and has more than just a renewed look. The OxyGeni employs a more versatile Micro USB charger. Every patient will receive a Micro USB Battery Pack to enable the patient to not only receive therapy on the move but also be able charge anywhere at any time. The battery life has also been extended to over 48 hours, while also offering improved accuracy of the battery status and the management of the charging function.  The OxyGeni also come with a choice of convenient carrying options.

The OxySpur Oxygen Diffusion Dressings have been updated with blue bubbles on the top in order to easily identify the top, occlusive layer of the dressing from bottom, foam layer. This improvement of the OxySpur will help make the patient’s task of changing their dressing at home, by instruction of their Clinician, even easier.

OxySpur Dressings are available in both adhesive and non-adhesive options. Making sure dressings stay in place in-between changes is essential. As a response to customer feedback the OxySpur Adhesive dressings have been upgraded to a stronger Hi Tac hydrocolloid adhesive. The dressing is designed to stay in place for up to 7 days.

As the COVID-19 pandemic has impeded many patients from being able to attend their routine wound care appointments, EO2 Concepts and their CDO Therapy have been able to offer physicians using telehealth programs more at-home therapy to patients, especially in the New York City area.

“We are happy to continue offering full closure and pain relief to our patients treated at home during this pandemic who can’t get to the wound care center ” said Joe Moffett, President and CEO of EO2 Concepts. “We are thankful for all of the wound care clinicians who continue to work through this crisis, and grateful that we could step in to help keep wound care patients out of the facilities Emergency Rooms”

About EO2

EO2 Concepts® is a privately held, advanced wound care technology company based in San Antonio, TX. As the developer of a progressive FDA cleared Class II, CE marked medical device, they provide Continuous Diffusion of Oxygen (CDO) Therapy. Through a combination of the OxyGeni, a wound monitoring system, and the OxySpur® Oxygen Diffusion Dressing they provide full closure and pain relief to patients suffering from difficult-to-heal wounds.

Source
EO2 Concepts

Related Links
https://eo2.com

Contact
Joe Moffett
President
j.moffett@eo2.com • 1.800.825.2979